Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2014

Jun 10, 2014

30826_dirs_2014-06-10_38cd39a8-f313-4d38-ad27-d9354fd28bd5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-06-06

Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-06 Common Stock M 20000 $5.87 Acquired 582432 Direct
2014-06-06 Common Stock F 5752 $20.41 Disposed 576680 Direct
2014-06-06 Common Stock M 10000 $3.33 Acquired 586680 Direct
2014-06-06 Common Stock F 1632 $20.41 Disposed 585048 Direct
2014-06-06 Common Stock M 21250 $6.23 Acquired 606298 Direct
2014-06-06 Common Stock F 6486 $20.41 Disposed 599812 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-06 Stock Option (Right to Buy) $5.87 M 20000 Disposed 2018-06-06 Common Stock (20000) Direct
2014-06-06 Stock Option (Right to Buy) $3.33 M 10000 Disposed 2020-07-15 Common Stock (10000) Direct
2014-06-06 Stock Option (Right to Buy) $6.23 M 21250 Disposed 2023-02-28 Common Stock (21250) Direct

Footnotes

F1: Payment made via forfeiture of 5,752 shares of Common Stock valued at the Closing Price of $20.41 on June 6, 2014.

F2: Payment made via forfeiture of 1,632 shares of Common Stock valued at the Closing Price of $20.41 on June 6, 2014.

F3: Payment made via forfeiture of 6,486 shares of Common Stock valued at the Closing Price of $20.41 on June 6, 2014.